10.18.2021
Improve Outcomes
$4,035,613.00
48 months
Analogue vs Human Insulin for Youth with Type 1 Diabetes in Low-Resource Settings: A Randomized Controlled Trial (AnHuT1D trial)
Support to generate high-quality, trial-derived evidence on the use of analogue insulins and the feasibility of using continuous glucose monitors for youth living with type 1 diabetes in low-resource settings.